BlackRock, Inc. 13D and 13G filings for Surmodics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2024-01-26 11:49 am Purchase |
2023-12-31 | 13G | Surmodics, Inc. SRDX |
BlackRock Inc. BLK |
1,080,288 7.600% |
65,532![]() (+6.46%) |
Filing |
2023-04-06 09:29 am Sale |
2023-03-31 | 13G | Surmodics, Inc. SRDX |
BlackRock Inc. BLK |
1,014,756 7.200% |
-1,297,751![]() (-56.12%) |
Filing |
2023-01-23 3:52 pm Purchase |
2022-12-31 | 13G | Surmodics, Inc. SRDX |
BlackRock Inc. BLK |
2,312,507 16.400% |
45,032![]() (+1.99%) |
Filing |
2022-02-07 4:41 pm Purchase |
2021-12-31 | 13G | Surmodics, Inc. SRDX |
BlackRock Inc. BLK |
2,267,475 16.300% |
50,707![]() (+2.29%) |
Filing |
2021-01-25 4:50 pm Purchase |
2020-12-31 | 13G | Surmodics, Inc. SRDX |
BlackRock Inc. BLK |
2,216,768 16.200% |
34,611![]() (+1.59%) |
Filing |